Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT04113109

1 development in the corpus

NCT04113109

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · PHASE 4 TRIAL

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2

ClinicalTrials.gov

This is a completed mechanistic Phase 4 crossover study testing a hypothesis about bradykinin's role in ARB/NEP inhibitor hypotension in heart failure; no results are reported in this registry record.

PreliminaryIcatibant Iohexol LCZ 696

Reported

Planned enrollment80

Actual enrollment46

PhasePHASE 4

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support